Abstract:
In this paper BuzzMetrics reviews findings from analyses of online consumer buzz for two sets of promising drug therapies. The therapies with pre-approval buzz experienced an enormous increase in discussion among relevant online communities versus those that had little or no pre-approval buzz. This suggests the value of a pharma brand's investment in even a small amount of pre-launch buzz.
This could also be of interest:
Research Papers
What the buzz?!!
Catalogue: Congress 2010: The Changing Face Of Market Research
Authors: Annette Druce, Kristin Hickey
Company: Ruby Cha Cha
September 15, 2010
Research Papers
The healthcare journey
Catalogue: Global Healthcare 2008: Consumer Choice
Authors: Lekshmy Parameswaran, Laura Nino
Company: Philips International
February 6, 2008
Research Papers
Recognizing hidden factors in healthcare innovation
Catalogue: Global Healthcare 2010: Trends And Innovation Booster
Author: Laura Lee
 
March 3, 2010
